Published in J Diabetes Sci Technol on November 01, 2009
Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care (2014) 3.00
Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol (2011) 2.44
Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care (2010) 1.66
Design of the health monitoring system for the artificial pancreas: low glucose prediction module. J Diabetes Sci Technol (2012) 1.14
Clinical hurdles and possible solutions in the implementation of closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol (2011) 1.10
Quest for the artificial pancreas: combining technology with treatment. IEEE Eng Med Biol Mag (2010) 1.09
Fault detection and safety in closed-loop artificial pancreas systems. J Diabetes Sci Technol (2014) 0.96
A Digital Ecosystem of Diabetes Data and Technology: Services, Systems, and Tools Enabled by Wearables, Sensors, and Apps. J Diabetes Sci Technol (2015) 0.91
The role of technology and the chronic care model. J Diabetes Sci Technol (2010) 0.91
Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support. J Diabetes Sci Technol (2012) 0.89
Innovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system). J Diabetes Sci Technol (2011) 0.81
Design and in silico evaluation of an intraperitoneal-subcutaneous (IP-SC) artificial pancreas. Comput Chem Eng (2014) 0.77
In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control. J Diabetes Sci Technol (2013) 0.76
Mobile remote-presence devices for point-of-care health care delivery. CMAJ (2013) 0.75
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care (2006) 5.20
Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care (2003) 3.43
Modular artificial beta-cell system: a prototype for clinical research. J Diabetes Sci Technol (2008) 2.42
Telemedical support to improve glycemic control in adolescents with type 1 diabetes mellitus. Eur J Pediatr (2006) 2.15
Dead-in-bed syndrome in diabetes mellitus and hypoglycaemic unawareness. Lancet (1997) 1.61
Using telemedicine to improve outcomes in diabetes--an emerging technology. J Diabetes Sci Technol (2009) 1.52
The INCA system: a further step towards a telemedical artificial pancreas. IEEE Trans Inf Technol Biomed (2008) 1.40
In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther (2009) 1.24
Telemedicine and diabetes management: current challenges and future research directions. J Diabetes Sci Technol (2008) 1.24
Store-and-forward teleneurology in developing countries. J Telemed Telecare (2001) 1.24
Swiss teleradiology survey: present situation and future trends. Eur Radiol (2005) 0.98
A telemedicine system that includes a personal assistant improves glycemic control in pump-treated patients with type 1 diabetes. J Diabetes Sci Technol (2007) 0.90
Computer-assisted surgery and computer-assisted telesurgery in otorhinolaryngology. Ear Nose Throat J (2006) 0.86
Use of digital camera imaging of eye fundus for telemedicine in children suspected of abusive head injury. Br J Ophthalmol (2008) 0.84
Dead-in-bed syndrome in diabetes mellitus. Lancet (1997) 0.82
Thyroid cancer: possible role of telemedicine. Acta Otorhinolaryngol Ital (2008) 0.81
Role of diet and insulin treatment of diabetes in pregnancy. Clin Obstet Gynecol (2000) 0.81
Teleradiology in Croatia. J Telemed Telecare (2001) 0.80
Anesthesia in remote locations: radiology and beyond, international anesthesiology clinics: CT and MRI. Int Anesthesiol Clin (2009) 0.80
Analysis: signs of illness: when will technology provide greater advantage than the practiced eye of the clinician (or the military commander)? Diabetes Technol Ther (2003) 0.80
Military diabetes and advanced technologies research. Diabetes Technol Ther (2003) 0.80
Robustness of cellular functions. Cell (2004) 6.65
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care (2006) 5.20
Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell (2007) 4.87
Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes (2012) 3.40
Dynamic flux balance analysis of diauxic growth in Escherichia coli. Biophys J (2002) 3.10
Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care (2014) 3.00
A novel computational model of the circadian clock in Arabidopsis that incorporates PRR7 and PRR9. Mol Syst Biol (2006) 2.48
Modular artificial beta-cell system: a prototype for clinical research. J Diabetes Sci Technol (2008) 2.42
Robustness properties of circadian clock architectures. Proc Natl Acad Sci U S A (2004) 2.31
Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell. Diabetes Care (2007) 2.30
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care (2013) 2.26
Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care (2010) 2.18
Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther (2007) 2.10
Importance of input perturbations and stochastic gene expression in the reverse engineering of genetic regulatory networks: insights from an identifiability analysis of an in silico network. Genome Res (2003) 2.09
A benchmark for methods in reverse engineering and model discrimination: problem formulation and solutions. Genome Res (2004) 2.06
Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board. J Diabetes Sci Technol (2009) 2.06
Bolus calculator: a review of four "smart" insulin pumps. Diabetes Technol Ther (2008) 1.96
Identification of small molecule activators of cryptochrome. Science (2012) 1.95
Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care (2006) 1.95
Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol (2008) 1.81
Iterative approach to model identification of biological networks. BMC Bioinformatics (2005) 1.80
Proposal for the reconsideration of the definition of gestational diabetes. Diabetes Care (2005) 1.78
Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker. Diabetes Technol Ther (2003) 1.74
Sensitivity analysis of discrete stochastic systems. Biophys J (2005) 1.70
Siphon effects on continuous subcutaneous insulin infusion pump delivery performance. J Diabetes Sci Technol (2010) 1.70
Clinical evaluation of a personalized artificial pancreas. Diabetes Care (2012) 1.69
Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care (2010) 1.66
Model-based blood glucose control for Type 1 diabetes via parametric programming. IEEE Trans Biomed Eng (2006) 1.63
Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol (2010) 1.62
Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care (2012) 1.57
Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol (2009) 1.55
A molecular model for intercellular synchronization in the mammalian circadian clock. Biophys J (2007) 1.54
Point: Oral hypoglycemic agents should not be used to treat diabetic pregnant women. Diabetes Care (2007) 1.47
A model of the cell-autonomous mammalian circadian clock. Proc Natl Acad Sci U S A (2009) 1.46
Point: yes, it is necessary to rely entirely on glycemic values for the insulin treatment of all gestational diabetic women. Diabetes Care (2003) 1.43
Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus. IEEE Trans Biomed Eng (2006) 1.39
Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric. Diabetes Care (2007) 1.36
Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther (2009) 1.34
A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes. J Process Control (2008) 1.31
In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther (2009) 1.24
Run-to-run control of meal-related insulin dosing. Diabetes Technol Ther (2005) 1.24
Control-relevant models for glucose control using a priori patient characteristics. IEEE Trans Biomed Eng (2011) 1.23
In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol (2009) 1.19
A neuropeptide speeds circadian entrainment by reducing intercellular synchrony. Proc Natl Acad Sci U S A (2013) 1.19
Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol (2003) 1.15
Practical issues in the identification of empirical models from simulated type 1 diabetes data. Diabetes Technol Ther (2007) 1.15
Design of the health monitoring system for the artificial pancreas: low glucose prediction module. J Diabetes Sci Technol (2012) 1.14
Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther (2009) 1.12
Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus. Diabetes Technol Ther (2007) 1.10
Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care (2012) 1.10
A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiol (2003) 1.09
Closed-loop control and advisory mode evaluation of an artificial pancreatic Beta cell: use of proportional-integral-derivative equivalent model-based controllers. J Diabetes Sci Technol (2008) 1.09
Quest for the artificial pancreas: combining technology with treatment. IEEE Eng Med Biol Mag (2010) 1.09
Glucose estimation and prediction through meal responses using ambulatory subject data for advisory mode model predictive control. J Diabetes Sci Technol (2007) 1.07
An improved PID switching control strategy for type 1 diabetes. IEEE Trans Biomed Eng (2008) 1.07
Progress in development of an artificial pancreas. J Diabetes Sci Technol (2009) 1.07
OmniPod Insulin Management System: patient perceptions, preference, and glycemic control. Diabetes Care (2006) 1.06
Energy-efficient pulse-coupled synchronization strategy design for wireless sensor networks through reduced idle listening. IEEE Trans Signal Process (2012) 1.06
Isochron-based phase response analysis of circadian rhythms. Biophys J (2006) 1.06
Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone. J Diabetes Sci Technol (2008) 1.05
Wavelet measurement suggests cause of period instability in mammalian circadian neurons. J Biol Rhythms (2011) 1.04
Quantitative performance metrics for robustness in circadian rhythms. Bioinformatics (2006) 1.04
Closed-loop control of artificial pancreatic Beta -cell in type 1 diabetes mellitus using model predictive iterative learning control. IEEE Trans Biomed Eng (2009) 1.03
Modeling cortisol dynamics in the neuro-endocrine axis distinguishes normal, depression, and post-traumatic stress disorder (PTSD) in humans. PLoS Comput Biol (2012) 1.03
Coordinated basal-bolus infusion for tighter postprandial glucose control in insulin pump therapy. J Diabetes Sci Technol (2009) 1.02
Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique. Diabetes Metab Res Rev (2007) 1.02
Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood) (2004) 1.02
Experimental evaluation of a recursive model identification technique for type 1 diabetes. J Diabetes Sci Technol (2009) 1.02
Gestational diabetes guidelines in a HAPO world. Best Pract Res Clin Endocrinol Metab (2010) 1.01
Decreased protein expression and intermittent recoveries in BiP levels result from cellular stress during heterologous protein expression in Saccharomyces cerevisiae. Biotechnol Prog (2002) 1.01
Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care (2007) 1.00
Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor. J Diabetes Sci Technol (2010) 1.00
Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev (2011) 0.99
Optimal phase response functions for fast pulse-coupled synchronization in wireless sensor networks. IEEE Trans Signal Process (2012) 0.99
Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev (2008) 0.99
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. Diabetes Technol Ther (2014) 0.99
Synchrony and entrainment properties of robust circadian oscillators. J R Soc Interface (2008) 0.99